QT Imaging (QTI) Q2 FY26 earnings call

QT Imaging delivered robust Q2 FY26 results, driven by significant growth in scanner shipments and revenue, affirming its full-year guidance. The company continues to build out its commercial, clinical, and regulatory foundations, expanding its US sales team and international presence while securing key regulatory clearances and a CPT reimbursement code. Despite a decline in gross margin and increased operating expenses, strategic investments in infrastructure and clinical evidence are positioning the company for broader adoption and sustainable growth.